Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $47.5 million.

  • Acadia Healthcare Company's Depreciation & Amortization (CF) rose 2610.72% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.0 million, marking a year-over-year increase of 2585.5%. This contributed to the annual value of $149.6 million for FY2024, which is 1303.07% up from last year.
  • According to the latest figures from Q3 2025, Acadia Healthcare Company's Depreciation & Amortization (CF) is $47.5 million, which was up 2610.72% from $49.0 million recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Depreciation & Amortization (CF) registered a high of $49.0 million during Q2 2025, and its lowest value of $24.9 million during Q1 2021.
  • For the 5-year period, Acadia Healthcare Company's Depreciation & Amortization (CF) averaged around $34.2 million, with its median value being $32.0 million (2023).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 625.35% in 2022, then skyrocketed by 3584.82% in 2025.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Depreciation & Amortization (CF) stood at $28.4 million in 2021, then increased by 6.25% to $30.1 million in 2022, then grew by 17.38% to $35.4 million in 2023, then rose by 11.76% to $39.5 million in 2024, then grew by 20.05% to $47.5 million in 2025.
  • Its last three reported values are $47.5 million in Q3 2025, $49.0 million for Q2 2025, and $47.0 million during Q1 2025.